Quantitative Chemical XPS Analysis

Added: Aug 17, 2017 11:51 am Pursuant to the authority of FAR 13.106-1(b)(1)(i), the Contracting Officer may solicit from one source if the Contracting Officer determines that the circumstances of the contract action deem only one source is reasonably available. The Department of Health and Human Services (DHHS), Program Support Center (PSC), Acquisition Management Services (AMS), on behalf of the Food and Drug Administration (FDA) intends to sole source to:

Anderson Materials Evaluation
9051 Red Branch Road, Suite C
Columbia, MD 21045

The FDA has a need for Quantitative Chemical X-ray Photoelectron Spectroscopic (XPS) analysis on 124 each membrane samples. The action to analyze these samples is deemed a follow on I/A/W FAR 6.302-1(a)(2). Anderson Materials Evaluations has previously performed analyses for FDA via a competitive process. Therefore, Anderson Materials Evaluations has the experience and has shown success in this analysis. A recurrence of this need warrants a follow on.

This is not a solicitation for competitive proposal. No solicitation document is available. All responsible sources that have determined that they can provide the same services may submit product information and a capabilities statement addressing their specific abilities regarding future requirements. The email subject line must reference 'XPS 080117'. All responses can be sent to the Contracting Officer at timothy.bouchelle@psc.hhs.gov.

A determination by the Government not to compete this proposed contract is solely within the discretion of the government.